Navigation Links
Otonomy Announces Preclinical Results Supporting Intra-operative Use of OTO-201 for Common Childhood Procedure
Date:6/8/2011

ren experience otitis media by the time they reach three years of age.  Oral antibiotics are considered standard of care for patients with otitis media due to infection. Patients with recurrent or persistent otitis media are routinely referred to ENT surgeons for placement of a tympanostomy tube in one or both ears. Industry sources estimate that approximately one million patients undergo tympanostomy tube placement surgery each year in the U.S.

About OtonomyOtonomy is a clinical stage biopharmaceutical company developing innovative therapeutics for diseases and disorders of the inner and middle ear.  There are currently no FDA-approved drug treatments for the nearly 30 million Americans that are affected by debilitating hearing and balance diseases and disorders such as Meniere's disease, sudden sensorineural hearing loss, noise-induced hearing loss, age-related hearing impairment and tinnitus.  Otonomy's core technology is a sustained release formulation developed for optimal delivery of drugs to the middle and inner ear with a single intratympanic (IT) injection.  This technology has broad applicability across a range of therapeutic classes and two products based on this platform are in active development.

Otonomy's lead product candidate, OTO-104, is a sustained release formulation of the steroid dexamethasone.  A Phase 1b clinical trial in Ménière's disease patients has recently been completed, and future studies are being planned in Meniere's disease and other inner ear disorders.  OTO-201, the company's second product candidate, is a novel sustained release antibiotic being developed for the treatment of chronic otitis media.  OTO-201 clinical trials are expected to begin in 2011.  Additional product candidates are expected to target acute and chronic forms of hearing loss, balance disorders, and tinnitus.

For more information visit: www.otonomy.com'/>"/>

SOURCE Otonomy, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Otonomy Appoints David A. Weber, Ph.D., Chief Executive Officer
2. Pharmasset Announces the Expansion of the ELECTRON Trial in Chronic Hepatitis C
3. Grifols Announces Combined Operations With Talecris to Begin a New Era as a Global Leader of Life-Saving Plasma Therapeutics
4. Edison Pharmaceuticals Announces FDA Grants EPI-743 Orphan Drug Designation
5. Boston Scientific Announces Favorable Appellate Court Ruling Affirming Invalidity of J&J Patents
6. Alere Inc. Announces Extension of Consent Solicitations Related to its 9.0% Senior Subordinated Notes Due 2016, 8.625% Senior Subordinated Notes Due 2018 and 7.875% Senior Notes Due 2016 and Increased Consent Fees
7. ImaginAb, Inc. Announces Availability of Custom Protein Radiolabeling Services for Molecular Imaging
8. Topaz Pharmaceuticals Announces New Drug Application for the Treatment of Head Lice Accepted by FDA
9. Ore Pharmaceutical Holdings Announces Name Change and Reverse/Forward Stock Split to be Effective June 10, 2011
10. Thoratec Announces Presentations at Upcoming Investor Conferences
11. COPAN Announces Strategic Global Distribution Partnership with Siemens
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... N.J. , March 5, 2015  Medical ... which specializes in high complexity, state-of-the-art, automated DNA-based ... new Human Papillomavirus (HPV) testing which utilizes cutting ... Each year, approximately 12,000 women are ... United States . Genital Human Papillomaviruses (HPV) ...
(Date:3/5/2015)... NEW YORK , March 5, 2015 /PRNewswire/ ... developing novel therapies for the treatment of chronic ... clinicians and researchers to advisory roles. The panel ... Relmada,s development programs and efforts to advance the ... chronic pain. They bring expertise in a range ...
(Date:3/5/2015)... N.J. , March 5, 2015  Celsion ... that the Company will host a conference call ... an update on its development programs for ThermoDox®, ... two newly acquired technology platforms, TheraPlas™ and TheraSilence™, ... ET on Thursday, March 12, 2015. To participate ...
Breaking Medicine Technology:Medical Diagnostic Laboratories, L.L.C., the Institute for Biomarker Research Announces New HPV Tests 2Medical Diagnostic Laboratories, L.L.C., the Institute for Biomarker Research Announces New HPV Tests 3Relmada Therapeutics Names Leading Clinicians and Researchers in Pain Therapy Development to Advisory Roles 2Relmada Therapeutics Names Leading Clinicians and Researchers in Pain Therapy Development to Advisory Roles 3Relmada Therapeutics Names Leading Clinicians and Researchers in Pain Therapy Development to Advisory Roles 4Celsion Corporation to Hold Year-End 2014 Financial Results Conference Call on Thursday, March 12, 2015 2
... , , PHILADELPHIA, Dec. 23 ... Colcrys® (colchicine, USP) Patient Assistance Program, an initiative that will ... This program reflects URL Pharma,s ongoing commitment to helping ... are able to access them, regardless of economic status. Colcrys ...
... , ATLANTA, Dec. 23 MiMedx Group, Inc. (OTC Bulletin ... first product, Paradis Vaso Shield(TM). In April 2009, The ... as a cover for vessels following anterior vertebral surgeries. ... protected by multiple patents and patent applications, as well as ...
Cached Medicine Technology:URL Pharma Launches Colcrys(R) Patient Assistance Program 2URL Pharma Launches Colcrys(R) Patient Assistance Program 3MiMedx Group Announces Launch of its Paradis Vaso Shield(TM) Device 2MiMedx Group Announces Launch of its Paradis Vaso Shield(TM) Device 3
(Date:3/6/2015)... March 06, 2015 Many patients with ... medical therapy. If you (or someone you know) have ... osteoarthritis, you may be interested in the ACT-OA clinical ... announced today that he is one of fifteen physicians ... to begin enrolling subjects as part of a new, ...
(Date:3/6/2015)... March 06, 2015 Truly Nolen, the ... to announce the grand opening of their first independently-owned ... area down to the Fort Mill – Rock Hill, ... February 27th, 2015 at their new location. ... years of collective experience in the pest control industry. ...
(Date:3/6/2015)... 2015 Yisrayl Hawkins, Pastor and Overseer ... released a new publication explaining how micro-kingdoms keep the ... The article titled “Microorganisms Do Much More Than You ... microorganisms were created and designed to keep all things ... of the functions of these micro-kingdom, but does not ...
(Date:3/6/2015)... March 06, 2015 FCPX developers ... Pixel Film Studios. , “Pro3rd Hue is a lower 3rd ... CEO of Pixel Film Studios. “Blurring the line between professional ... Pro3rd Hue is a set of 30 customizable lower third ... With Pro3rd Hue, FCPX users can complement any design with ...
(Date:3/6/2015)... Dr. Mark Sowell recently returned from leading a ... programs for advanced education in the field of dentistry, Spear ... As a visiting faculty member of this prestigious institution, Dr. ... he visits Spear Education to participate in a specialized workshop. ... training only the top 10% and those willing to sacrifice ...
Breaking Medicine News(10 mins):Health News:Kevin Darr, M.D. is Now Enrolling Patients in a New FDA-Approved Clinical Trial Evaluating Adipose-Derived Regenerative Cells in the Treatment of Knee Osteoarthritis 2Health News:First Truly Nolen Franchise Opening in North Carolina 2Health News:Yisrayl Hawkins Tells Scientists Exactly What Makes Life Function Properly in New Publication 2Health News:A New Plugin Entitled Pro3rd Hue was Released Today from Pixel Film Studios Exclusively for FCPX 2Health News:Plano Dentist Teaches Dentists from Around the Globe at Spear Education 2
... , SANTA CLARA, Calif., July 16 ... was featured recently in the New York Times Fashion & ... Dermatology New York University Medical Center and Founding Director, New ... Kauvar described the LightSheer Duet as a welcome relief for ...
... be linked to higher risk of heart attack, stroke, ... The U.S. Food and Drug Administration has begun a ... reports of an increased risk of heart attack, abnormal ... Thursday. , Early results from the Evaluating the Clinical ...
... , , , JANESVILLE, Wis., ... signing of design-build contracts totaling $53.9 million for St. Mary,s Janesville ... for Dean Janesville Clinic with Dean Health Systems, Inc. ... the third quarter, completion is expected sometime in late 2011. ...
... in unattended vehicles, experts warn , THURSDAY, July 16 (HealthDay ... warm weather, don,t even think about leaving a child unattended ... Highway Traffic Safety Administration (NHTSA) shows the leading cause of ... heat stroke. , "Even with the windows rolled down ...
... , , , , ... , , , FAIRFAX, ... looking to recognize a cancer survivor in the Chicago area who has ... local community. The winner of the Survivor Circle Award will receive $1,000 ...
... , ALEXANDRIA, Va., July 16 Ensuring that ... the event of a healthcare crisis is what advance care ... Care Organization,s Caring Connections, a leading provider of advance care ... the availability and accessibility of advance care planning information and ...
Cached Medicine News:Health News:Lumenis' High Speed LightSheer(R) Duet(TM) Featured in New York Times Fashion & Style for Eliminating 'Pain and Nuisance' of Hair Removal for Men 2Health News:Lumenis' High Speed LightSheer(R) Duet(TM) Featured in New York Times Fashion & Style for Eliminating 'Pain and Nuisance' of Hair Removal for Men 3Health News:Lumenis' High Speed LightSheer(R) Duet(TM) Featured in New York Times Fashion & Style for Eliminating 'Pain and Nuisance' of Hair Removal for Men 4Health News:Lumenis' High Speed LightSheer(R) Duet(TM) Featured in New York Times Fashion & Style for Eliminating 'Pain and Nuisance' of Hair Removal for Men 5Health News:FDA Investigating Safety of Asthma Drug Xolair 2Health News:Cogdell Spencer ERDMAN(SM) Announces the Signing of Contracts Totaling $88.8 Million in Janesville, Wisconsin 2Health News:Cogdell Spencer ERDMAN(SM) Announces the Signing of Contracts Totaling $88.8 Million in Janesville, Wisconsin 3Health News:Cars Are No Place for Kids to Be Alone 2Health News:Award Honors Chicago Cancer Survivor Who Gives Back 2Health News:Award Honors Chicago Cancer Survivor Who Gives Back 3Health News:Award Honors Chicago Cancer Survivor Who Gives Back 4Health News:National Hospice and Palliative Care Organization's Caring Connections and Google Health Offer New Way to Access Advance Directives Online 2
... 0.2ml sub-ambient block and automatic height adjusting ... up to 3C/second; Accurate block performance; Absolute ... than 0.5C within 15 seconds; Oil free ... storage of up to 60 programs; 0.2 ...
... The Gene Cycler unit is an inexpensive personal ... for the PCR process. Lightweight, with a small ... almost anywhere, including the researcher's desk. , The ... researchers who do not have access to a ...
... The Mastercycler personal is a high quality, ... and precise block homogeneity, the Mastercycler personal offers ... 25-well format can accommodate 25 x 0.2 ml ... in a 5 x 5 grid format. Like ...
... intuitive programming and almost completely noiseless operation ... cycler in the modern laboratory workplace. , ... heated lid allows a choice of 25x ... microplate of 5 x 5 in the ...
Medicine Products: